van de Vijver, D A M C <br/><br/>
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.  [electronic resource] 

 -  British journal of clinical pharmacology  Aug 2002 
 - 168-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2125.2001.01491.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antidepressive Agents, Tricyclic--therapeutic use<br/>Antiparkinson Agents--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Levodopa--therapeutic use<br/>Male<br/>Middle Aged<br/>Parkinson Disease--drug therapy<br/>Selective Serotonin Reuptake Inhibitors--therapeutic use<br/>Treatment Outcome